Time to first treatment and risk of disability pension in relapsing-remitting multiple sclerosis
- 10 June 2022
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 93 (8) , 858-864
Abstract
BackgroundInitiation of disease-modifying therapy early in the disease course of relapsing-remitting multiple sclerosis (RRMS) has demonstrated beneficial effects on clinical outcomes, but socioeconomic outcomes remain largely unexplored.ObjectiveTo investigate the association between the delay from disease onset to first treatment and the hazard of disability pension.MethodsWe performed a population-based cohort study with data from the nationwide Danish Multiple Sclerosis Registry and Danish nationwide registries. Patients with a disease onset between 1 January 1996 to 5 April 2016 were followed until disability pension or a competing risk/censoring event. 7859 patients were assessed for eligibility of which 5208 were included in the final cohort. Key inclusion criteria were: a diagnosis of multiple sclerosis, relapsing-remitting phenotype, treatment in history, age 18–65 years and an Expanded Disability Status Scale≤4. Patients were categorised according to time from onset to first treatment: within 1 year (early), between 1 and 4 years (intermediate) and from 4 to 8 years (late).ResultsOf the 5208 patients, 1922 were early, 2126 were intermediate and 1160 were late. Baseline clinical and socioeconomic variables were well balanced. The hazard of receiving disability pension increased with increasing delay of treatment initiation compared with the early group. Cox regression estimates adjusted for clinical and socioeconomic confounders: intermediate (HR, 1.37; 95% CI, 1.12 to 1.68) and late (HR, 1.97; 95% CI, 1.55 to 2.51).ConclusionEarly treatment initiation is associated with a reduced risk of disability pension in patients with RRMS. This finding underlines the importance of early diagnosis and treatment on a patient-centred, socioeconomic disability milestone.Keywords
Funding Information
- The Danish Multiple Sclerosis Society
This publication has 39 references indexed in Scilit:
- The Danish Civil Registration System as a tool in epidemiologyEuropean Journal of Epidemiology, 2014
- EDSS variability before randomization may limit treatment discovery in primary progressive MSMultiple Sclerosis Journal, 2012
- Competing risks in epidemiology: possibilities and pitfallsInternational Journal of Epidemiology, 2012
- Integration of Cognitive Impairment in the Expanded Disability Status Scale of 215 Patients with Multiple SclerosisEuropean Neurology, 2010
- The use and reporting of multiple imputation in medical research – a reviewJournal of Internal Medicine, 2010
- Early treatment: PreCISe-ly what the patient needsJournal of the Neurological Sciences, 2009
- Impact of multiple sclerosis relapses on progression diminishes with timeNeurology, 2009
- Will Rogers phenomenon in multiple sclerosisAnnals of Neurology, 2008
- Register-based follow-up of social benefits and other transfer payments: Accuracy and degree of completeness in a Danish interdepartmental administrative database compared with a population-based surveyScandinavian Journal of Public Health, 2007
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988